September 9 – 12, 2019

Westin Boston Waterfront

Boston, MA

The 2018 Clinical Biomarkers & World CDx Boston Summit continued to cement the biomarker and translational development content at the heart of the meeting, enabling attendees to take a journey along the whole development continuum from exploratory biomarker, through clinical validation, past regulatory and reimbursement hurdles and into a globally adopted drug-Dx product.

For 2018, the two overarching themes that underpinned the meeting where:

    1. Enhance the robust validation of next-generation predictive biomarker signatures to accelerate the development and approval of innovative targeted therapeutics
    2. Improving the uptake of high value precision medicines and diagnostic testing to progress the standard of care for patients worldwide.

Click below to find out more about our biomarker and diagnostic sides to the event.